Nindalieva150mg

Nindalieva 150mg Capsule contains the active ingredient Nintedanib. This medication falls under the category of tyrosine kinase inhibitors. It is used to treat idiopathic pulmonary fibrosis, chronic fibrosing interstitial lung disease, and interstitial lung disease associated with systemic sclerosis. If you are taking blood thinning medications or have recently had surgery, consult your physician. It is important to use effective contraception while taking this capsule and to continue for three months after your last dose. Speak with your doctor about reliable contraception methods, as birth control pills may not be effective for women in this situation.

Before beginning treatment, inform your doctor of any medical conditions you may have, including liver and heart issues. Your doctor may perform a liver function test at regular intervals during the first three months of treatment. If you have a history of bleeding or blood clots (arterial thromboembolic), notify your doctor. Nindalieva 150mg Capsule has the potential to cause liver function impairment (hepatic impairment) and embryo-fetal toxicity.

If you have any of these underlying conditions, consult your doctor. The most frequently reported side effects of Nindalieva 150mg Capsule include nausea, vomiting, diarrhea, fever, skin ulcers, gastrointestinal perforation, altered liver function tests, decreased appetite, headaches, weight loss, and hypertension. If you experience any side effects, inform your doctor immediately.